Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Duffaud

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2025
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement - OSAMA Study)Domenico Ferraioli, Fulvio Borella, Marie Meurer, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
Nature Communications|June 22, 2026
MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComaJustine Gantzer, Xiaofan Lu, Céline Charon-Barra, et al.
BMC Cancer|May 29, 2021
Determinants of the access to remote specialised services provided by national sarcoma reference centresYohan Fayet, Raphaël Tétreau, Charles Honoré, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Cancers|June 10, 2022
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?Yohan Fayet, Christine Chevreau, Gauthier Decanter, et al.
The Lancet Regional Health. Europe|August 13, 2025
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registryJean-Yves Blay, Maud Toulmonde, Thibaud Valentin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC databaseEmmanuelle Bompas, Loic Campion, Maud Toulmonde, et al.
BMC Cancer|January 20, 2023
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARCPierre Kubicek, Axel Le Cesne, Cyril Lervat, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2025
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement - OSAMA Study)Domenico Ferraioli, Fulvio Borella, Marie Meurer, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
Nature Communications|June 22, 2026
MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComaJustine Gantzer, Xiaofan Lu, Céline Charon-Barra, et al.
BMC Cancer|May 29, 2021
Determinants of the access to remote specialised services provided by national sarcoma reference centresYohan Fayet, Raphaël Tétreau, Charles Honoré, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Cancers|June 10, 2022
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?Yohan Fayet, Christine Chevreau, Gauthier Decanter, et al.
The Lancet Regional Health. Europe|August 13, 2025
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registryJean-Yves Blay, Maud Toulmonde, Thibaud Valentin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC databaseEmmanuelle Bompas, Loic Campion, Maud Toulmonde, et al.
BMC Cancer|January 20, 2023
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARCPierre Kubicek, Axel Le Cesne, Cyril Lervat, et al.
Pageof 14